Medical Developments International Limited
MVP.ASXHealth Care
Pharmaceutical drug business and medical and veterinary equipment business.
Market Data
$0.385
-0.0%$43.4M
-100000.0x
$-0.004
0.00%
-0.3%
Latest Earnings
FY26 Half Year Report (including Appendix 4D)
19 February 2026
Medical Developments International reported a loss of $0.2 million in H1 FY26 compared to a $0.3 million profit in the prior period, despite 8% revenue growth to $21.6 million. Pain Management segment performed strongly with 18% revenue growth driven by volume increases, while Respiratory revenue declined 10% due to softer US demand. Key points: Pain Management revenue up 18% driven by volume growth, with hospital segment demand up 26%; Continued growth of Penthrox in Europe with in-market volumes up 10% across all regions; Strong cash position of $16.9 million with positive operating cash flow of $0.3 million
Recent Announcements
FY26 Half Year Report (including Appendix 4D)
Medical Developments International reported a loss of $0.2 million in H1 FY26 compared to a $0.3 million profit in the prior period, despite 8% revenue growth to $21.6 million. Pain Management segment performed strongly with 18% revenue growth driven by volume increases, while Respiratory revenue declined 10% due to softer US demand. Key points: Pain Management revenue up 18% driven by volume growth, with hospital segment demand up 26%; Continued growth of Penthrox in Europe with in-market volumes up 10% across all regions; Strong cash position of $16.9 million with positive operating cash flow of $0.3 million
Get real-time alerts for MVP
Receive AI-powered earnings summaries and instant notifications when Medical Developments International Limited releases results.
Register Free